Chiesi Total CareSM AND patient support
Chiesi Total Care is a comprehensive support program that provides exceptional service to patients and healthcare providers
A single call to your dedicated Chiesi Total Care team is all it takes, and they will guide you through the process of getting a patient started on MYCAPSSA therapy. The Chiesi Total Care program provides assistance to patients with or without commercial insurance, Medicaid, and Medicare.*
- Patient must be enrolled in Chiesi Total Care. (Enrollment and Authorization Form will be mailed to your patient’s home)
- Patient must have commercial insurance and a valid prescription for a US FDA-approved indication for MYCAPSSA
- Patient must be a resident of the United States or one of its territories
Frequently Asked Questions About MYCAPSSA
Patients who respond to and tolerate octreotide or lanreotide may be eligible to take MYCAPSSA instead of receiving injections.2
GH, growth hormone; IGF-I, insulin-like growth factor 1.
Somavert® (pegvisomant for injection) is a subcutaneous injection, self-administered once daily after a physician-supervised initial loading dose.8 Somatuline® Depot (lanreotide) is for deep subcutaneous injection only, initially administered every 4 weeks by a healthcare professional.9 Sandostatin® LAR Depot (octreotide acetate) and Signifor® LAR (pasireotide) are intramuscular injections, administered monthly by a healthcare professional.10,11
Patients who respond to and tolerate octreotide or lanreotide may be eligible to take MYCAPSSA.
†Somavert® is a registered trademark of Pfizer Inc.
‡Somatuline Depot is a registered trademark of Ipsen Pharma S.A.S.
§Sandostatin® is a registered trademark of Novartis Pharmaceuticals Corporation.
||Signifor® is a licensed trademark of Recordati Rare Diseases Inc.
¶Please refer to the full Prescribing Information for each product for full Dosage and Administration information.
Chiesi Global Rare Diseases: Our commitment
Chiesi Global Rare Diseases is committed to helping address wellness within the rare disease community
We strive to provide unmatched support in the lives of people living with rare diseases. We work in close partnership with caregivers, patient communities, healthcare professionals, government authorities, and other stakeholders to help make an impact in the rare disease community. We relentlessly pursue sustainable development goals with passion, courage, teamwork, and innovation. We believe—from timely and accurate diagnoses to receiving treatments and finding supportive communities—that no one should feel alone.